Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current debate on hormone replacement therapy].

B Georges1, K Hermelink, M Untch

  • 1Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe-Grosshadern, Ludwig-Maximilians-Universität München. bianca.georges@med.uni-muenchen.de

Gynakologisch-Geburtshilfliche Rundschau
|April 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial.

ESMO open·2026
Same author

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival.

ESMO open·2025
Same author

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

ESMO open·2025
Same author

Corticotropin-Releasing Hormone (CRH) in Murine Narcolepsy: What Do Genetic and Immune Models Tell Us?

Journal of sleep research·2025
Same author

Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Influence of breast cancer on life satisfaction in the elderly patient.

Archives of gynecology and obstetrics·2025
Same journal

[Pelvic floor in pregnancy and after child birth: recommendations of the AUG Committee. Expert correspondence no. 29 of 31 July 2009].

Gynakologisch-geburtshilfliche Rundschau·2010
Same journal

[Water birth: control of infection and contraindications. Expert correspondence no. 27 of 26 May 2009].

Gynakologisch-geburtshilfliche Rundschau·2010
Same journal

[Current treatment options in postpartum hemorrhage. Expert correspondence no. 26 of 26 May 2009. ].

Gynakologisch-geburtshilfliche Rundschau·2010
Same journal

[Off label use of drugs in obstetric gynecology. 23rd consensus of of experts 19 October 2007].

Gynakologisch-geburtshilfliche Rundschau·2010
Same journal

[Hyperreactive luteomas during pregnancy--symptoms and complications: a case report].

Gynakologisch-geburtshilfliche Rundschau·2010
Same journal

[Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature].

Gynakologisch-geburtshilfliche Rundschau·2010
See all related articles

Hormone replacement therapy (HRT) use is debated following major studies. While HRT may aid menopause symptoms and bone health, its link to breast cancer risk requires careful consideration.

Area of Science:

  • Gynecology
  • Oncology
  • Endocrinology

Context:

  • Recent large-scale studies, including the Women's Health Initiative and Million Women Study, have prompted critical re-evaluation of hormone replacement therapy (HRT).
  • Ongoing scientific and public discourse surrounds the benefits and risks of HRT, particularly concerning its association with breast cancer.
  • Key German medical societies have issued statements on HRT, reflecting the lack of consensus.

Purpose:

  • To critically discuss the pros and cons of hormone replacement therapy in light of recent large-scale studies.
  • To examine the association between hormone replacement therapy and breast cancer risk.
  • To evaluate the established indications for HRT, including menopausal symptom management, osteoporosis prevention, and cognitive function, considering current evidence.

Related Experiment Videos

Summary:

  • Estrogen exposure is implicated in stimulating breast epithelium, with prolonged exposure potentially promoting breast cancer development.
  • The discussion encompasses HRT's role in managing climacteric symptoms, preventing osteoporosis, and potentially improving cognitive functions and preventing dementia.
  • Despite ongoing debate and differing opinions among medical societies, a definitive consensus on HRT's overall risk-benefit profile remains elusive.

Impact:

  • Informs clinical decision-making regarding hormone replacement therapy prescriptions.
  • Highlights the need for personalized risk-benefit assessments for patients considering HRT.
  • Contributes to the ongoing scientific dialogue on hormone therapy and its long-term health implications, particularly in relation to breast cancer.